Production (Stage)
Sunshine Biopharma, Inc.
SBFM
$1.54
-$0.055-3.45%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -52.99% | -40.55% | -35.23% | -41.67% | -9.64% |
Total Receivables | 21.84% | 51.56% | 58.24% | 97.56% | 57.93% |
Inventory | 54.03% | 96.66% | 117.42% | 99.74% | 107.49% |
Prepaid Expenses | 12.86% | 264.87% | 1,856.91% | 1,560.28% | 472.16% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -15.09% | 4.32% | 2.15% | -1.34% | 15.57% |
|
|||||
Total Current Assets | -15.09% | 4.32% | 2.15% | -1.34% | 15.57% |
Net Property, Plant & Equipment | 41.80% | 46.37% | 13.32% | 2.56% | -8.60% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 54.59% | 109.08% | 141.96% | 98.37% | 117.84% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -8.50% | 11.75% | 8.70% | 3.14% | 18.18% |
|
|||||
Total Accounts Payable | 38.98% | 114.39% | 87.19% | 180.15% | 32.12% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 85.44% | 75.06% | -1.27% | -6.22% | -4.86% |
Total Finance Division Other Current Liabilities | -81.31% | -80.19% | -90.73% | -90.82% | -30.76% |
Total Other Current Liabilities | -81.31% | -80.19% | -90.73% | -90.82% | -30.76% |
Total Current Liabilities | -11.80% | 13.75% | -11.00% | 13.72% | -5.39% |
|
|||||
Total Current Liabilities | -11.80% | 13.75% | -11.00% | 13.72% | -5.39% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 45.31% | 38.16% | -20.77% | -22.45% | -18.94% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 13.26% | 13.26% | 13.26% |
Total Liabilities | -8.40% | 14.98% | -11.77% | 9.64% | -6.38% |
|
|||||
Common Stock & APIC | 4.31% | 10.59% | 8.68% | 6.39% | 11.80% |
Retained Earnings | -7.72% | -8.03% | -6.74% | -5.93% | -6.69% |
Treasury Stock & Other | -627.43% | -219.24% | -17.56% | -202.71% | -11.91% |
Total Common Equity | -8.53% | 10.76% | 13.95% | 1.59% | 27.68% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | 0.00% | 1,200.00% | 1,200.00% | 1,200.00% | 1,200.00% |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 1,200.00% | 1,200.00% | 1,200.00% | 1,200.00% |
|
|||||
Total Common Equity | -8.53% | 10.76% | 13.95% | 1.59% | 27.68% |
Total Preferred Equity | 0.00% | 1,200.00% | 1,200.00% | 1,200.00% | 1,200.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -8.53% | 10.81% | 14.00% | 1.64% | 27.74% |
|